We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc
SPPI

Delisted

SPPI was delisted on the 31st of July, 2023.

Back to rankings

146 hedge funds and large institutions have $297M invested in Spectrum Pharmaceuticals Inc in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 38 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $111K | Put options by funds: $32K

55% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 38

4% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 23

1% less funds holding

Funds holding: 148 → 146 (-2)

7% less capital invested

Capital invested by funds: $318M → $297M (-$21.3M)

Holders
146
Holders Change
-2
Holders Change %
-1.35%
% of All Funds
3.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
59
Reduced
38
Closed
23
Calls
$111K
Puts
$32K
Net Calls
+$79K
Net Calls Change
-$190K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$11.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$4.68M
3
RFC
Russell Frank Company
Washington
+$3.62M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.77M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.73M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$15.1M
2
State Street
State Street
Massachusetts
-$12.1M
3
ACA
Avoro Capital Advisors
New York
-$7.87M
4
ACM
Ashford Capital Management
Delaware
-$7.32M
5
NI
Numeric Investors
Massachusetts
-$3.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIP
151
Convergence Investment Partners
Florida
– -$1.49M -248,302 Closed
DMK
152
David M. Knott
– -$1.45M -242,700 Closed
PP
153
PDT Partners
New York
– -$1.12M -187,594 Closed
First Trust Advisors
154
First Trust Advisors
Illinois
– -$724K -121,103 Closed
TAM
155
Tocqueville Asset Management
New York
– -$598K -100,000 Closed
NCCM
156
Nine Chapters Capital Management
New Jersey
– -$499K -83,400 Closed
SCM
157
Stevens Capital Management
Pennsylvania
– -$361K -60,410 Closed
GCP
158
GSA Capital Partners
United Kingdom
– -$349K -58,400 Closed
HI
159
Horizon Investments
North Carolina
– -$139K -23,257 Closed
CSS
160
Cubist Systematic Strategies
Connecticut
– -$113K -18,900 Closed
SEI Investments
161
SEI Investments
Pennsylvania
– -$113K -18,895 Closed
Group One Trading
162
Group One Trading
Illinois
– -$86.2K -15,072 Closed
AC
163
Amici Capital
New York
– -$90K -15,000 Closed
CAM
164
Concorde Asset Management
Michigan
– -$84K -14,000 Closed
OC
165
Oppenheimer & Co
New York
– -$80K -13,455 Closed
SG Americas Securities
166
SG Americas Securities
New York
– -$79K -13,228 Closed
VKH
167
Virtu KCG Holdings
New York
– -$75K -12,566 Closed
VCM
168
Versant Capital Management
Arizona
– +$435 +76 New
3 4 5 6
7

SPPI Hedge Fund Activity: Q4 2015 in Review

146 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2015, worth a combined $297M — down 6.7% from $318M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SPPI and 22 opened new positions — a net loss of 1 holder — while 38 trimmed existing stakes and 59 added.

The largest buyer was Acadian Asset Management, adding an estimated $11.3M. The largest seller was Broadfin Capital, exiting entirely with an estimated $15.1M sold.

  • 146 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2015, down from 148 in Q3 2015.
  • Funds reported $297M of Spectrum Pharmaceuticals Inc stock for Q4 2015, down 6.7% quarter-over-quarter.
  • 22 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2015 and 23 closed out, a net change of -1 holder.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2015 was Acadian Asset Management, an estimated $11.3M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2015 was Broadfin Capital, an estimated $15.1M sold.

Based on aggregated 13F filings for Q4 2015.